Results 181 to 190 of about 161,071 (201)

INTERLEUKIN-1 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST: FROM BENCH TO BEDSIDE

Inflammatory Bowel Diseases, 1996
A C, Stevens, M, Peppercorn
openaire   +2 more sources

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

Lancet, The, 2012
Daniel F Freitag, Peter Willeit, Pei Gao
exaly  

Emapalumab/etoposide/interleukin-1-receptor-antagonist

Reactions Weekly, 2022
openaire   +1 more source

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

Lancet, The, 2012
Daniel I Swerdlow, Michael V Holmes, Karoline B Kuchenbaecker   +2 more
exaly  

Interleukin-1 Receptor Antagonist

2015
openaire   +1 more source

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

Lancet, The, 2008
Josef S Smolen, Andrea Rubbert-Roth, César R Ramos-Remus   +2 more
exaly  

Interleukin 1 Receptor Antagonist Measurement

2020
openaire   +1 more source

Recombinant Interleukin-1 Receptor Antagonist

2020
openaire   +1 more source

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

Nature Reviews Drug Discovery, 2012
Charles A Dinarello, Anna Simon, Jos W M Van Der Meer   +2 more
exaly  

Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis

New England Journal of Medicine, 2012
Ka Papp, Alan Menter, James G Krueger
exaly